𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hypofibrinolysis in patients with hypercoagulability: The roles of urokinase and of plasminogen activator inhibitor

✍ Scribed by Herbert K. F. Lau; Jerome M. Teitel; To Cheung; Sam K. P. Kung; M. Bernadette Garvey

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
545 KB
Volume
44
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Expression of urokinase-type plasminogen
Expression of urokinase-type plasminogen activator and plasminogen activator inhibitor in colon disease
✍ Slobodan Miseljic; Susan Galandiuk; Stephen D. Myers; Dr. James L. Wittliff πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 488 KB πŸ‘ 1 views

Surveillance colonoscopy and biopsy are inaccurate methods of predicting the likelihood of ulcerative colitis patients to develop colon carcinoma. We examined uPA and PAI-1 as potential markers for assessing these patients and those with familial polyposis who are at risk of developing colon cancer.

Clinical relevance of urokinase plasmino
Clinical relevance of urokinase plasminogen activator, its receptor, and its inhibitor in patients with renal cell carcinoma
✍ Rainer Hofmann; Antonie Lehmer; Markus Buresch; Rudolf Hartung; Kurt Ulm πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 559 KB

## BACKGROUND. Urokinase plasminogen activator (u-PA) plays a key role in the metastatic process by promoting plasmin mediated tissue degradation. Metastatic cell invasion requires localized proteolysis, which may be directed by u-PA receptor. The binding of u-PA and PAI-1 to the u-PA-receptor may

Two distinct expression patterns of urok
Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases
✍ Martin Illemann; Nigel Bird; Ali Majeed; Ole D. LΓ¦rum; Leif R. Lund; Keld DanΓΈ; πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 1012 KB

## Abstract Metastatic growth and invasion by colon cancer cells in the liver requires the ability of the cancer cells to interact with the new tissue environment. Plasmin(ogen) is activated on cell surfaces by urokinase‐type PA (uPA), and is regulated by uPAR and plasminogen activator inhibitor‐1